M&A Deal Summary |
|
|---|---|
| Date | 2022-04-19 |
| Target | Meridian HealthComms |
| Sector | Business Services |
| Buyer(s) | Bioscript |
| Deal Type | Add-on Acquisition |
SEARCH BY
Bioscript is an international provider of medical communications and regulatory writing services for pharmaceutical companies. The business assists clients in their communications with regulatory authorities as well as educating the medical sector on pharmaceutical products that are in mid-to-late-stage clinical trials and subsequently supporting these products, post-market launch, to maintain and grow sales throughout the lifecycle of the drug. Bioscript was founded in 2005 and is based in Cheshire, United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 3 |
| Sector: Business Services M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 3 of 3 |
| Country: United Kingdom M&A | 3 of 3 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-08-10 |
Valid Insight
London, United Kingdom Valid Insight is an award-winning consultancy working with clients to deliver pricing, reimbursement, market access, and payer value communication strategies through the full product development cycle, supporting optimal patient access to new and innovative health technologies. Valid Insight was established in 2016 and is based in London, United Kingdom. |
Buy | - |
